Financials Clarity Medical Group Holding Limited
Equities
1406
KYG2181S1084
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.52 HKD | -1.89% | -3.70% | -17.46% |
Valuation
Fiscal Period: März | 2022 | 2023 |
---|---|---|
Capitalization 1 | 637.1 | 496.4 |
Enterprise Value (EV) 1 | 416.1 | 336.2 |
P/E ratio | 36.2 x | -154 x |
Yield | - | - |
Capitalization / Revenue | 2.83 x | 2.32 x |
EV / Revenue | 1.85 x | 1.57 x |
EV / EBITDA | 9.63 x | -218 x |
EV / FCF | 1,03,86,982 x | -1,40,40,310 x |
FCF Yield | 0% | -0% |
Price to Book | 2.49 x | 1.91 x |
Nbr of stocks (in thousands) | 5,09,718 | 5,28,125 |
Reference price 2 | 1.250 | 0.9400 |
Announcement Date | 27/07/22 | 28/07/23 |
Income Statement Evolution (Annual data)
Fiscal Period: März | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net sales 1 | 206.6 | 218.4 | 222.4 | 225.2 | 213.8 |
EBITDA 1 | 63.7 | 45.89 | 54.7 | 43.19 | -1.543 |
EBIT 1 | 57.21 | 39.09 | 46.32 | 35.49 | -7.722 |
Operating Margin | 27.69% | 17.9% | 20.83% | 15.75% | -3.61% |
Earnings before Tax (EBT) 1 | 39.45 | 33.17 | 43.82 | 19.05 | -2.917 |
Net income 1 | 30.04 | 26.39 | 35.77 | 13.49 | -3.191 |
Net margin | 14.54% | 12.08% | 16.08% | 5.99% | -1.49% |
EPS 2 | 0.1110 | 0.0941 | 0.0954 | 0.0346 | -0.006108 |
Free Cash Flow | - | -4.187 | 91.96 | 40.06 | -23.95 |
FCF margin | - | -1.92% | 41.35% | 17.78% | -11.2% |
FCF Conversion (EBITDA) | - | - | 168.12% | 92.74% | - |
FCF Conversion (Net income) | - | - | 257.11% | 296.9% | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 31/01/22 | 31/01/22 | 31/01/22 | 27/07/22 | 28/07/23 |
Balance Sheet Analysis
Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - |
Net Cash position 1 | 15.6 | 31.5 | 52.9 | 221 | 160 |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow | - | -4.19 | 92 | 40.1 | -23.9 |
ROE (net income / shareholders' equity) | - | 32.7% | 35.2% | 8.03% | -1.24% |
ROA (Net income/ Total Assets) | - | 19.5% | 20.2% | 10.9% | -1.56% |
Assets 1 | - | 135.1 | 177 | 123.9 | 204.1 |
Book Value Per Share 2 | 0.1500 | 0.4400 | 0.2100 | 0.5000 | 0.4900 |
Cash Flow per Share 2 | 0.1300 | 0.2400 | 0.1700 | 0.4700 | 0.3900 |
Capex 1 | 6.2 | 5.62 | 9.18 | 0.21 | 30.2 |
Capex / Sales | 3% | 2.57% | 4.13% | 0.09% | 14.12% |
Announcement Date | 31/01/22 | 31/01/22 | 31/01/22 | 27/07/22 | 28/07/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.46% | 35.87M | |
-18.52% | 16.2B | |
+5.41% | 12.73B | |
+3.98% | 11.68B | |
+4.36% | 10.22B | |
+28.07% | 8.6B | |
-4.98% | 7.78B | |
+6.76% | 6.73B | |
+7.33% | 6.4B | |
+48.17% | 4.49B |
- Stock Market
- Equities
- 1406 Stock
- Financials Clarity Medical Group Holding Limited